Creative Peptides news

New York, United States—Oct 10, 2022—Creative Peptides, the leading biotechnology company focusing on peptides, today announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand.

“Our peptide chemists have successfully manufactured Fmoc-Tyr(HP03Bzl)-OH with purities of 90% and 95%. We reserved in-stock products that have passed quality tests and are ready to

Creative Peptides today released custom PNA probe services for clients' specific research needs. As a leading biomedical technology company engaged in PNA studies, the company can meet customers' requirements by providing a high level of quality control for the design and synthesis of each custom PNA probe project.

Peptide nucleic acids (PNAs) are unique oligonucleotide mimics with strong specific recognition ability and excellent chemical and biological stabilities. Expe

New York, United States—May 23, 2022—Creative Peptides has been involved in synthesizing peptide nucleic acid (PNA) for years and gained tremendous experience in PNA synthesis, modification, and purification. Creative Peptides’ product portfolio consists of standard Fmoc-PNA monomers and Boc-PNA monomers that can be ordered in large quantities with high purity, solubility, and reactivity, as well as other backbone- and base-modified PNA products.

Peptide nucleic acid